Scimega Research Scimega Research

U.S. drug developers turn to Scimega upon realizing program timelines and targets aren’t being met, and marvel at what is then accomplished within a country 1/10th the size of the U.S. The Scimega team consistently achieves clinical trial start-up times 50% faster than the North American average, with trial sites often among top enrollers in global oncology studies.

With a real appreciation for the value of these results Scimega’s U.S. clients frequently return for next phase trials and additional studies ever earlier in their drug development process.

Contact for more information:
Julie Martin, M.Sc., MBA, Director, Clinical Operations
Montreal, Canada
Office: (450) 629-2200 ext.231

Make an enquiry

Follow this company

Follow the company to be always up to date with this company


Scimega Research Images

Products and Services


Related Projects

Press Release

Regional Offices

Contact company

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.